Company: DTSQ
Filing Date: 2025-11-28
Form Type: 8-K
Source: 0001493152-25-025378
Chunk: 0

Company: DT Cloud Star Acquisition Corp
Filing Date: 2025-11-28
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.

On
November 26, 2025, the board of directors of DT Cloud Star Acquisition Corporation (the “ Company”) appointed Dr. Xunyong
Zhou as a director of the Company.

Dr.
Zhou, aged 50, is an entrepreneur and researcher with over 6 years of experience in biotechnology and health innovation. Dr.
Zhou’s main topic of research is enzyme-based theory for food products, cosmetics, daily chemicals and tea, and he holds over
20 patents as of now. Dr. Zhou is a pioneering figure in biotechnology and digital health innovation. He has served as director for
Huakang Biomedical Holdings Company Limited (HK: 08622) since November 2025. Since January 2023, He has been leading advancements in
biological enzyme solutions and cell therapy technologies through Nanjing Hezhen Holding Group Co., Ltd., where he serves as
chairman and integrates healthcare generative pre-training transformer and enzyme therapy expertise to co-create a collaborative
platform offering next-generation health solutions. Dr. Zhou also oversees Changsha Kerong Health Technology Co., Ltd., which has
built a multidisciplinary health service team comprising medical, product, and service experts centered on delivering AI-enhanced
health education, health consultation, and health management services. From March 2019 to January 2023, Dr. Zhou took the role of
chairman for Zhenzhen Suqian Biotechnology Co. Ltd..

Dr.
Zhou graduated from Tianjin University of the PRC with a bachelor degree of engineering majoring in business administration in 2002 and
Fudan University of the PRC with a master degree of laws in 2011. Dr. Zhou subsequently obtained his doctorate degree in business administration
from the Université Nice Sophia Antipolis in Nice, France in 2016. He is currently the honorary chairman of the Vaccine and Immune
Health Branch of the Liaoning Immunology Society and a member of the National Enzyme Engineering and Fermentation Engineering Professional
Committee.

   2  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Dated:
November 28, 202